[1]
|
Kitahara, C.M. and Sosa, J.A. (2016) The Changing Incidence of Thyroid Cancer. Nature Reviews Endocrinology, 12, 646-653. https://doi.org/10.1038/nrendo.2016.110
|
[2]
|
Kilfoy, B.A., et al. (2009) International Patterns and Trends in Thyroid Cancer Incidence, 1973-2002. Cancer Causes & Control, 20, 525-531. https://doi.org/10.1007/s10552-008-9260-4
|
[3]
|
李哲轩, 张阳, 周彤, 等. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
|
[4]
|
李宾, 姜晓峰. 代谢综合征的研究进展[J]. 国际检验医学杂志, 2018, 39(24): 2996-3001.
|
[5]
|
Carioca, A.A.F., Steluti, J., de Carvalho, A.M., et al. (2021) Plasma Metabolomics Are Associated with Metabolic Syndrome: A Targeted Approach. Nutrition, 83, Article ID: 111082.
|
[6]
|
中华人民共和国国家卫生健康委员会. 甲状腺癌诊疗规范(2018年版) [J]. 中华普通外科学文献(电子版), 2019, 13(1): 1-15.
|
[7]
|
佚名. 中国成人血脂异常防治指南(2016年修订版) [J]. 中华心血管病杂志, 2016.
|
[8]
|
White, C.P. (1909) On the Occurrence of Crystals in Tumors. The Journal of Pathology and Bacteriology, 13, 3-10.
https://doi.org/10.1002/path.1700130103
|
[9]
|
Tulinius, H., Sigfússon, N., Sigvaldason, H., et al. (1997) Risk Factors for Malignant Diseases: A Cohort Study on a Population of 22,946 Icelanders. Cancer Epidemiology Biomarkers & Prevention, 6, 863-873.
|
[10]
|
Ulmer, H., Borena, W., Rapp, K., et al. (2009) Serum Triglyceride Concentrations and Cancer Risk in a Large Cohort Study in Austria. British Journal of Cancer, 101, 1202-1206. https://doi.org/10.1038/sj.bjc.6605264
|
[11]
|
Radišauskas, R., Kuzmickienė, I., Milinavičienė, E., et al. (2016) Hypertension, Serum Lipids and Cancer Risk: A Review of Epidemiological Evidence. Medicina, 52, 89-98. https://doi.org/10.1016/j.medici.2016.03.002
|
[12]
|
张美娜, 万雪婷. 南昌市第三医院健康体检人群甲状腺结节与血脂水平, 胰岛素抵抗的相关性分析[J]. 江西医药, 2021, 56(2): 4.
|
[13]
|
Zhang, J., Song, Y., Shi, Q., et al. (2021) Research Progress on FASN and MGLL in the Regulation of Abnormal Lipid Metabolism and the Relationship between Tumor Invasion and Metastasis. Frontiers of Medicine, 15, 649-656.
https://doi.org/10.1007/s11684-021-0830-0
|
[14]
|
Liu, C., Zhou, X., Pan, Y., et al. (2021) Pyruvate Carboxylase Promotes Thyroid Cancer Aggressiveness through Fatty Acid Synthesis. BMC Cancer, 21, Article No. 722. https://doi.org/10.1186/s12885-021-08499-9
|
[15]
|
Pedersen, K.M., Olak, Y., Bojesen, S.E., et al. (2020) Low High-Density Lipoprotein and Increased Risk of Several Cancers: 2 Population-Based Cohort Studies Including 116,728 Individuals. Journal of Hematology & Oncology, 13, Article No. 129. https://doi.org/10.1186/s13045-020-00963-6
|
[16]
|
Mondul, A.M., Weinstein, S.J., Virtamo, J. and Albanes, D. (2011) Serum Total and HDL Cholesterol and Risk of Prostate Cancer. Cancer Causes & Control, 22, Article No. 1545. https://doi.org/10.1007/s10552-011-9831-7
|
[17]
|
Oh, H.Y., Lee, E.J., Yoon, S., Chung, B.H., Cho, K.S. and Hong, S.J. (2007) Cholesterol Level of Lipid Raft Microdomains Regulates Apoptotic Cell Death in Prostate Cancer Cells through EGFR-Mediated Akt and ERK Signal Transduction. The Prostate, 67, 1061-1069. https://doi.org/10.1002/pros.20593
|
[18]
|
Loosen, S.H., Kostev, K., Luedde, M., et al. (2021) Low Blood Levels of High-Density Lipoprotein (HDL) Cholesterol Are Positively Associated with Cancer. Journal of Cancer Research and Clinical Oncology, 4-11.
https://doi.org/10.1007/s00432-021-03867-1
|
[19]
|
Revilla, G., Pons, M., Baila-Rueda, L., et al. (2019) Cholesterol and 27-Hydroxycholesterol Promote Thyroid Carcinoma Aggressiveness. Scientific Reports, 9, Article No. 10260. https://doi.org/10.1038/s41598-019-46727-2
|
[20]
|
Gebhard, C., Maafi, F., Stähli, B.E., et al. (2018) Apolipoprotein A-I Proteolysis in Aortic Valve Stenosis: Role of Cathepsin S. Basic Research in Cardiology, 113, Article No. 30. https://doi.org/10.1007/s00395-018-0689-7
|
[21]
|
Yao, X.L., Gordan, E.M., Figueroa, D.M., et al. (2016) Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease. American Journal of Respiratory Cell and Molecular Biology, 55, 159-169. https://doi.org/10.1165/rcmb.2016-0060TR
|
[22]
|
黄坤寨, 肖方森, 张福星, 等. 载脂蛋白A1通过Wnt/β-catenin信号通路调控EMT在甲状腺癌转移中的作用[J]. 华中科技大学学报(医学版), 2019, 48(1): 9-14.
|
[23]
|
Ma, M., Wang, M., Zhang, Z., et al. (2021) Apolipoprotein A1 Is Negatively Associated with Male Papillary Thyroid Cancer Patients: A Cross-Sectional Study of Single Academic Center in China. BMC Endocrine Disorders, 21, Article No. 69. https://doi.org/10.1186/s12902-021-00714-9
|
[24]
|
Robbins, R.J. (2003) Statins Sentence Thyroid Cancer Cells to Death Rho. Journal of Clinical Endocrinology & Metabolism, 88, 3019-3020.
|
[25]
|
Mario, V., Di, M.T., Guido, R., et al. (1999) Prenyltransferase Inhibitors Induce Apoptosis in Proliferating Thyroid Cells through a p53-Independent CrmA-Sensitive, and Caspase-3-Like Protease-Dependent Mechanism. Endocrinology, 140, 698-704. https://doi.org/10.1210/endo.140.2.6494
|
[26]
|
Smith, P.F., Grossman, S.J., Gerson, R.J., et al. (1991) Studies on the Mechanism of Simvastatin-Induced Thyroid Hypertrophy and Follicular Cell Adenoma in the Rat. Toxicologic Pathology, 19, 197-205.
https://doi.org/10.1177/019262339101900301
|
[27]
|
Mascitelli, L. and Goldstein, M.R. (2015) Statin Immunomodulation and Thyroid Cancer. Clinical Endocrinology, 82, 620. https://doi.org/10.1111/cen.12600
|
[28]
|
Trivedi, L.U., Mbuntum, L.F., Halm, E.A., et al. (2021) Is Statin Use Associated with Risk of Thyroid Diseases? Results of a Retrospective Cohort Study. Annals of Pharmacotherapy, 55, 1110-1119.
https://doi.org/10.1177/1060028020986552
|
[29]
|
Kushchayeva, Y., Jensen, K., Burman, K.D., et al. (2014) Repositioning Therapy for Thyroid Cancer: New Insights on Established Medications. Endocrine-Related Cancer, 21, R183-R194. https://doi.org/10.1530/ERC-13-0473
|